The expression of a transgene coding for a chimeric molecule, containi
ng the cytoplasmic and transmembrane domains of the beta 1-integrin ch
ain and the extracellular domain of the T-cell differentiation antigen
CD4, was targeted to the mouse mammary gland by the mouse mammary tum
or virus (MMTV) promoter. The chimera does not interact with the extra
cellular ligands; however, its expression in cultured cells was shown
to interfere with focal adhesion kinase (FAK) phosphorylation followin
g ligation of endogenous beta 1-integrin, Therefore, expression of the
transgenic protein on the cell surface should uncouple adhesion from
intracellular events associated with the beta 1-cytoplasmic domain and
thus perturb beta 1-integrin functions. Although most of the transgen
ic females were able to lactate, their mammary glands had a phenotype
clearly distinct from that of wild-type mice. At mid-pregnancy and the
beginning of lactation, transgenic glands were underdeveloped and the
epithelial cell proliferation rates were decreased, while the apoptos
is levels were higher than in wild-type glands. In lactation, the amou
nts of the whey acidic protein (WAP) and beta-casein gene transcripts
were diminished, and the basement membrane component, laminin and the
beta 4-integrin chain accumulated at the lateral surface of luminal ep
ithelial cells, revealing defects in polarization. Our observations pr
ove that in vivo, beta 1-integrins are involved in control of prolifer
ation, apoptosis, differentiation and maintenance of baso-apical polar
ity of mammary epithelial cells, and therefore are essential for norma
l mammary gland development and function.